Insider Transactions in Q3 2021 at Dermata Therapeutics, Inc. (DRMA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2021
|
Christopher J. Nardo Senior VP, CDO |
BUY
Conversion of derivative security
|
Indirect |
2,439
+50.0%
|
-
|
|
Aug 17
2021
|
Thomas Insley Chief Financial Officer |
BUY
Conversion of derivative security
|
Indirect |
4,581
+24.22%
|
-
|
|
Aug 17
2021
|
Wendell Wierenga |
BUY
Conversion of derivative security
|
Direct |
8,163
+38.5%
|
-
|
|
Aug 17
2021
|
Proehl Investment Ventures LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,988,227
+14.67%
|
-
|
|
Aug 17
2021
|
David F Hale |
BUY
Open market or private purchase
|
Indirect |
35,714
+50.0%
|
-
|
|
Aug 17
2021
|
David F Hale |
BUY
Conversion of derivative security
|
Indirect |
278,291
+10.58%
|
-
|
|
Aug 17
2021
|
Munera Maria E Bedoya Toro SVP, Regulatory Affairs |
BUY
Conversion of derivative security
|
Indirect |
64,631
+19.05%
|
-
|
|
Aug 17
2021
|
Gerald T Proehl President, CEO and Chairman |
BUY
Open market or private purchase
|
Indirect |
142,857
+48.31%
|
-
|
|
Aug 17
2021
|
Gerald T Proehl President, CEO and Chairman |
BUY
Conversion of derivative security
|
Indirect |
2,050,779
+27.92%
|
-
|
|
Aug 16
2021
|
Gerald T Proehl President, CEO and Chairman |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$40,000
$4.96 P/Share
|